Vericel Corp. (VCEL)
40.50
+0.60
(+1.50%)
USD |
NASDAQ |
Sep 01, 16:00
40.85
+0.35
(+0.86%)
Pre-Market: 08:59
Vericel Net Income (TTM) : 24.22M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.22M |
| March 31, 2026 | 21.46M |
| December 31, 2025 | 16.52M |
| September 30, 2025 | 13.08M |
| June 30, 2025 | 7.107M |
| March 31, 2025 | 2.978M |
| December 31, 2024 | 10.36M |
| September 30, 2024 | 3.548M |
| June 30, 2024 | 0.789M |
| March 31, 2024 | 0.451M |
| December 31, 2023 | -3.182M |
| September 30, 2023 | -10.25M |
| June 30, 2023 | -13.17M |
| March 31, 2023 | -17.11M |
| December 31, 2022 | -16.71M |
| September 30, 2022 | -18.10M |
| June 30, 2022 | -16.45M |
| March 31, 2022 | -11.27M |
| December 31, 2021 | -7.471M |
| September 30, 2021 | 0.214M |
| June 30, 2021 | 8.763M |
| March 31, 2021 | 4.28M |
| December 31, 2020 | 2.864M |
| September 30, 2020 | 0.145M |
| June 30, 2020 | -0.003M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.53M |
| December 31, 2019 | -9.665M |
| September 30, 2019 | -13.92M |
| June 30, 2019 | -18.46M |
| March 31, 2019 | -3.322M |
| December 31, 2018 | -8.137M |
| September 30, 2018 | -13.09M |
| June 30, 2018 | -17.43M |
| March 31, 2018 | -15.17M |
| December 31, 2017 | -17.29M |
| September 30, 2017 | -23.77M |
| June 30, 2017 | -25.04M |
| March 31, 2017 | -25.69M |
| December 31, 2016 | -19.57M |
| September 30, 2016 | -18.28M |
| June 30, 2016 | -16.02M |
| March 31, 2016 | -15.13M |
| December 31, 2015 | -16.34M |
| September 30, 2015 | -13.80M |
| June 30, 2015 | -16.30M |
| March 31, 2015 | -18.79M |
| December 31, 2014 | -21.34M |
| September 30, 2014 | -23.29M |
| June 30, 2014 | -20.02M |
| March 31, 2014 | -20.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AbbVie, Inc. | 6.274B |
| ADMA Biologics, Inc. | 168.96M |
| Kyntra Bio, Inc. | -30.91M |
| Conexeu Sciences, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 380.48M |